This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enanga, B.
Right arrow Articles by Barrett, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enanga, B.
Right arrow Articles by Barrett, M. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2003, p. 3368-3370, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3368-3370.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Activity of Megazol, a Trypanocidal Nitroimidazole, Is Associated with DNA Damage

Bertin Enanga,1 Mark R. Ariyanayagam,2 Mhairi L. Stewart,1 and Michael P. Barrett1*

Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ,1 Division of Biological Chemistry and Molecular Microbiology, School of Life Sciences, Wellcome Trust Biocentre, University of Dundee, Dundee DD1 5EH, Scotland, United Kingdom2

Received 1 May 2003/ Returned for modification 19 June 2003/ Accepted 18 July 2003

DNA damage associated with the trypanocidal activity of megazol [2-amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole] was shown in experiments in which DNA repair-deficient RAD51-/- Trypanosoma brucei mutants were found to be hypersensitive to the drug. Parasites resistant to megazol were selected and showed modest cross-resistance to other trypanocides, although neither drug efflux nor changes to intracellular thiols correlated with resistance.


* Corresponding author. Mailing address: University of Glasgow, Institute of Biomedical and Life Sciences, Division of Infection and Immunity, The Joseph Black Building, Glasgow G12 8QQ, United Kingdom. Phone and fax: 44-141-330-6904. E-mail: m.barrett{at}bio.gla.ac.uk.


Antimicrobial Agents and Chemotherapy, October 2003, p. 3368-3370, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3368-3370.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Faundez, M., Lopez-Munoz, R., Torres, G., Morello, A., Ferreira, J., Kemmerling, U., Orellana, M., Maya, J. D. (2008). Buthionine Sulfoximine Has Anti-Trypanosoma cruzi Activity in a Murine Model of Acute Chagas' Disease and Enhances the Efficacy of Nifurtimox. Antimicrob. Agents Chemother. 52: 1837-1839 [Abstract] [Full Text]  
  • Stewart, M. L., Boussard, C., Brun, R., Gilbert, I. H., Barrett, M. P. (2005). Interaction of Monobenzamidine-Linked Trypanocides with the Trypanosoma brucei P2 Aminopurine Transporter. Antimicrob. Agents Chemother. 49: 5169-5171 [Abstract] [Full Text]  
  • Faundez, M., Pino, L., Letelier, P., Ortiz, C., Lopez, R., Seguel, C., Ferreira, J., Pavani, M., Morello, A., Maya, J. D. (2005). Buthionine Sulfoximine Increases the Toxicity of Nifurtimox and Benznidazole to Trypanosoma cruzi. Antimicrob. Agents Chemother. 49: 126-130 [Abstract] [Full Text]  
  • Stewart, M. L., Bueno, G. J., Baliani, A., Klenke, B., Brun, R., Brock, J. M., Gilbert, I. H., Barrett, M. P. (2004). Trypanocidal Activity of Melamine-Based Nitroheterocycles. Antimicrob. Agents Chemother. 48: 1733-1738 [Abstract] [Full Text]